Previous close | 79.18 |
Open | 78.57 |
Bid | 78.80 x 300 |
Ask | 78.84 x 200 |
Day's range | 78.38 - 78.93 |
52-week range | 60.47 - 79.25 |
Volume | |
Avg. volume | 5,328,583 |
Market cap | 244.317B |
Beta (5Y monthly) | 0.16 |
PE ratio (TTM) | 39.01 |
EPS (TTM) | 2.02 |
Earnings date | 25 Jul 2024 |
Forward dividend & yield | 1.45 (1.83%) |
Ex-dividend date | 22 Feb 2024 |
1y target est | 82.74 |
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Astrazeneca (AZN) have what it takes? Let's find out.
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
WILMINGTON, Del., May 22, 2024--AstraZeneca advances its ambition to redefine cancer care with new data across its industry-leading portfolio and pipeline at the American Society of Clinical Oncology (ASCO) Annual Meeting, May 31 to June 4, 2024.